A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel

Clinical trial NCT07019233 · RECRUITING

Trial details

NCT number: NCT07019233
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Real Time Pressure Controller Breast Cancer Albumin Paclitaxel Peripheral Neuropathy

Start date: 2024-09-01
Primary completion: 2025-12-31
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.